Literature DB >> 15928295

IGF-1: old growth factor shines as new drug target.

Ken Garber.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15928295     DOI: 10.1093/jnci/97.11.790

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  13 in total

Review 1.  Lung cancer therapeutics that target signaling pathways: an update.

Authors:  M Roshni Ray; David Jablons; Biao He
Journal:  Expert Rev Respir Med       Date:  2010-10       Impact factor: 3.772

Review 2.  Targeted medical therapy of biliary tract cancer: recent advances and future perspectives.

Authors:  Michael Hopfner; Detlef Schuppan; Hans Scherubl
Journal:  World J Gastroenterol       Date:  2008-12-14       Impact factor: 5.742

Review 3.  A review of treatment of uterine leiomyosarcomas.

Authors:  Nicholas Reed
Journal:  Curr Oncol Rep       Date:  2013-12       Impact factor: 5.075

Review 4.  Treatment of gastrointestinal neuroendocrine tumors with inhibitors of growth factor receptors and their signaling pathways: recent advances and future perspectives.

Authors:  Michael Höpfner; Detlef Schuppan; Hans Scherübl
Journal:  World J Gastroenterol       Date:  2008-04-28       Impact factor: 5.742

Review 5.  Defining the pathway to insulin-like growth factor system targeting in cancer.

Authors:  Steven A Rosenzweig; Hanudatta S Atreya
Journal:  Biochem Pharmacol       Date:  2010-06-23       Impact factor: 5.858

6.  Parity-induced decrease in systemic growth hormone alters mammary gland signaling: a potential role in pregnancy protection from breast cancer.

Authors:  Robert K Dearth; David A Delgado; Jill K Hiney; Thushangi Pathiraja; Steffi Oesterreich; Dan Medina; W Les Dees; Adrian V Lee
Journal:  Cancer Prev Res (Phila)       Date:  2010-02-09

7.  Addiction to elevated insulin-like growth factor I receptor and initial modulation of the AKT pathway define the responsiveness of rhabdomyosarcoma to the targeting antibody.

Authors:  Liang Cao; Yunkai Yu; Isaac Darko; Duane Currier; Linnia H Mayeenuddin; Xiaolin Wan; Chand Khanna; Lee J Helman
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

8.  PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancer.

Authors:  A Belfiore; M Genua; R Malaguarnera
Journal:  PPAR Res       Date:  2009-07-07       Impact factor: 4.964

Review 9.  Growth factor receptors and related signalling pathways as targets for novel treatment strategies of hepatocellular cancer.

Authors:  Michael Höpfner; Detlef Schuppan; Hans Scherübl
Journal:  World J Gastroenterol       Date:  2008-01-07       Impact factor: 5.742

10.  BMS-536924 reverses IGF-IR-induced transformation of mammary epithelial cells and causes growth inhibition and polarization of MCF7 cells.

Authors:  Beate C Litzenburger; Hyun-Jung Kim; Isere Kuiatse; Joan M Carboni; Ricardo M Attar; Marco M Gottardis; Craig R Fairchild; Adrian V Lee
Journal:  Clin Cancer Res       Date:  2009-01-01       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.